Your browser doesn't support javascript.
loading
Association of PIK3CA mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma.
Ugai, Tomotaka; Zhao, Melissa; Shimizu, Takashi; Akimoto, Naohiko; Shi, Shanshan; Takashima, Yasutoshi; Zhong, Rong; Lau, Mai Chan; Haruki, Koichiro; Arima, Kota; Fujiyoshi, Kenji; Langworthy, Benjamin; Masugi, Yohei; da Silva, Annacarolina; Nosho, Katsuhiko; Baba, Yoshifumi; Song, Mingyang; Chan, Andrew T; Wang, Molin; Meyerhardt, Jeffrey A; Giannakis, Marios; Väyrynen, Juha P; Nowak, Jonathan A; Ogino, Shuji.
Afiliação
  • Ugai T; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Zhao M; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Shimizu T; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Akimoto N; Department of Cardiovascular Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
  • Shi S; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Takashima Y; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Zhong R; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Lau MC; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Haruki K; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Arima K; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Fujiyoshi K; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Langworthy B; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Masugi Y; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • da Silva A; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Nosho K; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Baba Y; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Song M; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Chan AT; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Wang M; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Meyerhardt JA; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
  • Giannakis M; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Väyrynen JP; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.
  • Nowak JA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Ogino S; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Oncoimmunology ; 10(1): 1956173, 2021.
Article em En | MEDLINE | ID: mdl-34377593
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Antígeno B7-H1 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Antígeno B7-H1 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Oncoimmunology Ano de publicação: 2021 Tipo de documento: Article